Showing 1 - 9 of 9
We develop a model of the efficiency of medical testing based on the frequency of negative CT scans for pulmonary embolism. The model is estimated using a 20% sample of Medicare claims from 2000-2009. We document enormous heterogeneity in testing conditional on patient population. Less...
Persistent link: https://www.econbiz.de/10010951314
Persistent link: https://www.econbiz.de/10010920733
Persistent link: https://www.econbiz.de/10010921086
Local opinion leaders may play a key role in easing information frictions associated with technology adoption. This paper analyzes the influence of physician investigators who lead pivotal clinical trials for new cancer drugs. By comparing diffusion patterns across many drugs, we separate...
Persistent link: https://www.econbiz.de/10011133500
Information technology has been linked to productivity growth in a wide variety of sectors, and health information technology (HIT) is a leading example of an innovation with the potential to transform industry-wide productivity. This paper analyzes the impact of health information technology...
Persistent link: https://www.econbiz.de/10010753452
Medicare Part D enrollees face a complicated decision problem: they must dynamically choose prescription drug consumption in each period given difficult- to-find prices and a non-linear budget set. We use Medicare Part D claims data from 2006-2009 to estimate a flexible model of consumption that...
Persistent link: https://www.econbiz.de/10011189090
We explore choice inconsistency over time within the Medicare Part D Prescription Drug Program. Using the full universe of Part D claims data, we revisit our earlier work on partial data to replicate our results showing large "foregone savings" among Part D enrollees. We also document that this...
Persistent link: https://www.econbiz.de/10010951145
This paper investigates the degree to which choice inconsistencies documented in the context of Medicare Part D plan choice vary across consumers and geographic regions. Our main finding is that there is surprisingly little variation: regardless of age, gender, predicted drug expenditures or the...
Persistent link: https://www.econbiz.de/10009132646
We evaluate the choices of elders across their insurance options under the Medicare Part D Prescription Drug plan, using a unique dataset of prescription drug claims matched to information on the characteristics of choice sets. We document that elders place much more weight on plan premiums than...
Persistent link: https://www.econbiz.de/10009144829